
Juvena Therapeutics is a computationally-driven biopharmaceutical company focused on discovering and developing novel biologic medicines derived from secreted proteins to restore tissue homeostasis…

Juvena Therapeutics is a computationally-driven biopharmaceutical company focused on discovering and developing novel biologic medicines derived from secreted proteins to restore tissue homeostasis…
Position Description
Juvena Therapeutics is seeking a seasoned and strategic leader to join our executive team as the Vice President of Chemistry, Manufacturing, and Controls (CMC). Reporting directly to the SVP of Drug Development, this pivotal role will be responsible for defining and executing the comprehensive CMC strategy for our portfolio from discovery through to clinical-stage development. The successful candidate will lead all aspects of process development, analytical development, and manufacturing, guiding our novel candidates from pre-clinical development and lead optimization through regulatory filings, formulation optimization, scaling, clinical trials and commercialization. The VP of CMC will have expertise in biologics manufacturing and delivery, fusion proteins, and mammalian cell line-based protein synthesis. He/she will have experience and a strong understanding of the requirements for pre-filled syringes as well as drug-device combination development.
This is a critical leadership position requiring a blend of deep technical expertise, strategic vision, and operational excellence. The VP of CMC will oversee a primarily outsourced manufacturing model, building and managing strong relationships with a network of Contract Development and Manufacturing Organizations (CDMOs). The successful candidate will also oversee internal small scale production, protein engineering and lead optimization activities for assets in discovery and preclinical development. As a key member of the leadership team, you will collaborate across functions to ensure that our CMC activities are fully aligned with our clinical, regulatory, and corporate goals.
Company Summary
Juvena Therapeutics is a clinical stage, venture-backed biotech company leveraging its AI-enabled platform to discover and advance tissue restorative biologics to tackle chronic muscle and metabolic diseases. The company’s approach stems from mapping the therapeutic potential of stem-cell secreted proteins and translating them into a growing pipeline of engineered biologics. Juvena is achieving this through a fully integrated, end-to-end platform, JuvNET, that combines a compounding database leveraging quantitative proteomics, multi-omics, and high content imaging to map secreted proteins to specific disease phenotypes, utilizing in silico and in vitro human cell screening, pharmacology, and protein engineering capabilities. Juvena is progressing multiple clinical and preclinical programs, including a clinical stage, muscle regenerative biologic and a novel preclinical lipolysis inducing obesity asset with a unique mechanism.
Juvena’s lead asset, JUV-161, is a muscle regenerating fusion protein with broad indication potential, currently in Phase 1 studies in healthy volunteers, with the aim of developing the drug candidate for Myotonic Dystrophy Type 1 (DM1). Juvena’s obesity candidate, JUV-112, is based on a novel secreted protein with an orthogonal, non-appetite suppressing, energy expenditure based MOA (non-GLP-1/GIP mediated) for improved fat metabolism, including improved insulin sensitivity and adipose regulation. JUV-112 is currently in lead optimization. Juvena is also identifying muscle targeting pro-metabolic and hypertrophic secreted proteins for Sarcopenic Obesity, with an active discovery collaboration with Eli Lilly. Additionally, Juvena has discovered and validated 55+ hits across 6 therapeutic areas including fibrotic, hepatic, pulmonary, metabolic, osteopathies and inflammatory diseases.
Juvena’s venture-backed preclinical programs were also supported by funding from the National Institute of Health (NIH) and the California Institute of Regenerative Medicine (CIRM). At Juvena we embrace a diversity of backgrounds, experience and approaches that all combine to lead us to world-class scientific results in an inclusive environment. To learn more about Juvena Therapeutics, visit JuvenaTherapeutics.com or follow the company on LinkedIn @Juvena-Therapeutics.
Position Location and work permit requirement
640 Galveston Dr. Redwood City, 94063
Strong preference for onsite work at our office, but open to hybrid or remote working arrangements.
Candidates must be legally authorized to work in the U.S.
Key Responsibilities
Position Qualifications
Compensation
Career Opportunities at Juvena Therapeutics, Inc.
At Juvena Therapeutics, we believe everyone deserves a seat at the table and an equal chance at success, regardless of gender, race, sexual orientation, religion, ethnicity, cultural heritage, or
age. Most importantly, we are an equal opportunity employer and respect an individual’s right to freedom of expression within the boundaries of mutual respect and equal treatment.
We are seeking to grow our company with a diverse team of enthusiastic scientists and technologists who share our vision and determination to discover and develop tissue-restorative biologics to tackle muscle, metabolic, and age-related chronic diseases and promote healthspan. Explore all our open positions, and let’s grow together at https://www.juvenatherapeutics.com/careers/.
Please email your CV and Cover Letter to apply@juvenatherapeutics.com with the title of the position as the subject line.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,500+
New This Week